Top Tweets for #RETATRUTIDE

Will Retatrutide Get Harder to Find once approved? Breaking Down Lilly's Latest Data Join the Inner Circle here: https://t.co/TruBqmGxJg Have you read the new TRIUMPH-3 data? Let me know your thoughts in the comments. Participants on the highest dose of Retatrutide lost an average of: 70.3 lbs. 28.3% body weight reduction. Nearly HALF lost 30%+ of their body weight That’s getting into bariatric surgery territory. What makes Retatrutide different? Unlike traditional GLP-1s, this is a triple agonist targeting: • GLP-1 • GIP • Glucagon receptors The glucagon component may be one of the biggest reasons we’re seeing next-level fat loss and metabolic effects. (I talked about my side effects at the Q&A w/ the next level fat loss) Disclaimer: This video is for educational and informational purposes only. I am not a doctor, and nothing in this video should be considered medical advice. I am discussing research compounds and publicly available clinical trial information only. Retatrutide remains an investigational medication and has not yet received FDA approval for weight management. #Peptides #GLP1 #Retatrutide #ResearchPeptides #WeightLossJourney